|
01 Jul 2019 |
PTC Therapeutics Announces Strategic Gene Therapy Licensing Agreement with Odylia Therapeutics
|
|
01 Jul 2019 |
Boehringer Ingelheim Expands Nonalcoholic Steatohepatitis (NASH) R&D Pipeline With New First-in-Class Compound from Yuhan Corporation
|
|
01 Jul 2019 |
PeptiDream Announces New Peptide Drug Conjugate (“PDC”) Collaboration Agreement with Novartis
|
|
27 Jun 2019 |
Seelos Therapeutics Announces Acquisition of an Exclusive Worldwide License of Gene Therapy Program to Address Parkinson’s Disease from Duke University
|
|
27 Jun 2019 |
ImmunoGen Announces Completion of Operational Review
|
|
27 Jun 2019 |
OncoSec Receives Exclusive Licensing Rights from Dana-Farber Cancer Institute to CAR T-Cell Therapies for the Treatment of Solid Tumor Cancers
|
|
25 Jun 2019 |
AbbVie to Acquire Allergan in Transformative Move for Both Companies
|
|
25 Jun 2019 |
ERYTECH Announces Immune Modulation Strategic Collaboration with SQZ Biotechnologies
|
|
25 Jun 2019 |
C4X Discovery and PhoreMost collaboration to accelerate Parkinson’s Disease drug discovery pipeline
|
|
25 Jun 2019 |
Gilead and Carna Biosciences Announce Research and Development Collaboration to Develop Novel Immuno-Oncology Therapies
|
|
25 Jun 2019 |
Almirall Exercises its Option with Dermira to License Rights to Lebrikizumab in Europe for Atopic Dermatitis
|
|
21 Jun 2019 |
Spero Therapeutics Announces Collaboration with Bill & Melinda Gates Medical Research Institute to Develop SPR720 for Tuberculosis
|
|
20 Jun 2019 |
Ultragenyx and Arcturus Therapeutics Expand Existing Research Collaboration and License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
|
|
20 Jun 2019 |
Gilead and Nurix Establish Strategic Collaboration to Develop Novel Therapies for Cancer and Other Diseases
|
|
20 Jun 2019 |
Amgen And The Institute For Protein Design (IPD) At University Of Washington Announce Unique Strategic Research Partnership
|
|
19 Jun 2019 |
Denovo Biopharma Receives Global Rights to a Novel Late-Stage Drug for Alzheimer's Disease from Orion Corporation for Development as a Personalized Medicine
|
|
17 Jun 2019 |
Voyager Therapeutics Announces Restructured Gene Therapy Relationship with Sanofi Genzyme and Portfolio Update
|
|
17 Jun 2019 |
Intralytix, the Eliava Foundation and Ferring Pharmaceuticals Sign Joint Collaboration Agreement for Reproductive Medicine and Women's Health Initiatives
|
|
17 Jun 2019 |
Pfizer to Acquire Array BioPharma
|
|
13 Jun 2019 |
AbCellera Announces Therapeutic Antibody Discovery Collaboration with Gilead in Infectious Disease
|
|
12 Jun 2019 |
Sobi acquires emapalumab and related assets
|
|
11 Jun 2019 |
Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody®-CD38
|
|
11 Jun 2019 |
BiomX Licenses Novel Targets for Liver Disease Phage Therapy Program From JSR Corporation in Japan
|
|
10 Jun 2019 |
Merck to Acquire Tilos Therapeutics
|
|
07 Jun 2019 |
Vertex Expands into New Disease Areas and Enhances Gene Editing Capabilities Through Expanded Collaboration with CRISPR Therapeutics and Acquisition of Exonics Therapeutics
|
